Baxter International Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2025: 9.48%

Baxter International Inc. EBITDA Margin is 9.48% for the Trailing 12 Months (TTM) ending March 31, 2025, a -27.37% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Baxter International Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was 13.05%, a -334.42% change year over year.
  • Baxter International Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was -5.57%, a -129.81% change year over year.
  • Baxter International Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 18.68%, a -2.59% change year over year.
  • Baxter International Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was 19.18%, a 17.94% change year over year.
Key Data
Date EBITDA Margin Net Income Margin EBT Margin Operating Income Margin